Abstract:Background Glioblastoma, the most common primary malignant tumor of the brain, is associated with poor prognosis. Glioblastoma cells exhibit high proliferative and invasive properties, and glioblastoma stem cells (GSCs) have been shown to play a crucial role in the malignant behavior of glioblastoma cells. This study aims to investigate the molecular mechanisms involved in GSCs maintenance and malignant progression. Methods Bioinformatics analysis was performed based on data from public databases to explore the expression profile of Mitotic arrest deficient 2 like 2 (MAD2L2) and its potential function in glioma. The impact of MAD2L2 on glioblastoma cell behaviors was assessed through cell viability assays (CCK8), colony formation assays, 5-Ethynyl-2ʹ-deoxyuridine (EDU) incorporation assays, scratch assays, and transwell migration/invasion assays. The findings from in vitro experiments were further validated in vivo using xenograft tumor model. GSCs were isolated from the U87 and LN229 cell lines through flow cytometry and the stemness characteristics were verified by immunofluorescence staining. The sphere-forming ability of GSCs was examined using the stem cell sphere formation assay. Bioinformatics methods were conducted to identified the potential downstream target genes of MAD2L2, followed by in vitro experimental validation. Furthermore, potential upstream transcription factors that regulate MAD2L2 expression were confirmed through chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays. Results The MAD2L2 exhibited high expression in glioblastoma samples and showed significant correlation with patient prognosis. In vitro and in vivo experiments confirmed that silencing of MAD2L2 led to decreased proliferation, invasion, and migration capabilities of glioblastoma cells, while decreasing stemness characteristics of glioblastoma stem cells. Conversely, overexpression of MAD2L2 enhanced these malignant behaviors. Further investigation revealed that MYC proto-oncogene (c-MYC) mediated the functional role of MAD2L2 in glioblastoma, which was further validated through a rescue experiment. Moreover, using dual-luciferase reporter gene assays and ChIP assays determined that the upstream transcription factor E2F-1 regulated the expression of MAD2L2. Conclusion Our study elucidated the role of MAD2L2 in maintaining glioblastoma stemness and promoting malignant behaviors through the regulation of c-MYC, suggesting its potential as a therapeutic target.

LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion

Long Noncoding RNA LINC00052 Suppressed the Proliferation, Migration and Invasion of Glioma Cells by Upregulating KLF6.

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma

Construction of LASS2 gene recombinant adenovirus and its effect on the inhibition of metastasis of hepatocellular carcinoma cell line HCCLM3

Knockdown of Lncrna HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells

Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer

LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP

Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT in vitro and in vivo

Decreased expression of LASS2 is associated with worse prognosis in meningiomas

Silencing of Lncrna LBX2-AS1 Suppresses Glioma Cell Proliferation and Metastasis Through the Akt/GSK3β Pathway in Vitro.

LIMP-2 Enhances Cancer Stem-Like Cell Properties by Promoting Autophagy-Induced GSK3β Degradation in Head and Neck Squamous Cell Carcinoma

LASS2 Gene Inhibits the Metastasis of Human Hepatocellular Carcinoma HCCLM3 Cells

LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity

Silencing of a Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Promotes Invasion of Prostate Cancer Cell in Vitro Through Increase of Vacuolar ATPase Activity

Long Noncoding RNA CASC2 Predicts the Prognosis of Glioma Patients and Functions As a Suppressor for Gliomas by Suppressing Wnt/β-catenin Signaling Pathway

LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition

Silencing of LASS2/TMSG1 Enhances Invasion and Metastasis Capacity of Prostate Cancer Cell

The Promoting Effect and Mechanism of MAD2L2 on Stemness Maintenance and Malignant Progression in Glioma.

Chromatin Remodeling Factor Lsh Is Upregulated By The Lrp6-Gsk3(Beta)-E2f1 Axis Linking Reversely With Survival In Gliomas

Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.

Long Non-Coding RNA CASC2 Suppresses Malignancy in Human Gliomas by Mir-21.